Give Your Members Access to Published International Prices Without Adding a Vendor
US commercial prices sit at 254% of Medicare and haven't budged since 2018. Your members can now compare published procedure prices from JCI or equivalent nationally accredited international hospitals, and you don't need to exchange a single file to make it happen.
No commitment. No data exchanged. No cost.
Price Comparison Preview
| Procedure | US Commercial Price | International Price Examples |
|---|---|---|
| Coronary Artery Bypass (CABG) | $57,240 - $89,094 | India $7,900 | Spain $10,734 | Turkey $13,900 |
| Hip Replacement (Total) | $28,167 - $50,564 | India $7,200 | Spain $6,623 | Turkey $13,900 |
| Spinal Fusion (Single Level) | $80,000 - $150,000 | Thailand $9,500 | India $10,300 | Mexico $15,400 |
Why Healthcare Cost Containment Has Plateaued
A small number of claims drive the majority of plan costs.
254%
of Medicare rates: what US commercial insurers pay for hospital services
RAND Corporation, Hospital Price Transparency Study, Round 5.1, May 2024
The top 5% of claimants account for 49.7% of total spending (AHRQ, 2025). Million-dollar claims hit 221 per million covered employees in 2024, up 61% in four years (Sun Life, 2025). The procedures driving this (cardiac, spinal, orthopaedic, bariatric) are exactly where international price gaps are largest.
Domestic tools have hit their ceiling. International price benchmarking offers an external reference point that reference-based pricing, narrow networks, and bundled payments cannot. And with 155 ERISA fiduciary suits filed in 2025, the question isn't whether international pricing data exists. It's whether your fiduciary process evaluated it.
How an International Healthcare Marketplace Works
A directory and booking-infrastructure layer. No care coordination, no clinical relationship.
Sylk Health is a directory and booking-infrastructure layer that lists JCI or equivalent nationally accredited international providers and transmits consultation booking requests between patients and providers.
Here's what that looks like in practice. Providers upload their procedure prices, estimated wait times, and consultation availability. Patients browse, compare prices across providers, pick one, choose an available timeslot, and submit their email. The booking request goes to both patient and provider. The provider confirms. After that, patient and provider deal with each other directly.
That's a searchable catalogue of 1,954 procedures with US and international pricing, published by the providers themselves. Most platforms in international care require you to call, fill out a form, or "request a quote." Sylk Health shows the numbers.
Sylk Health doesn't sit inside the clinical relationship. It doesn't arrange travel, hold patient funds, issue binding quotes, run second-opinion services, or make provider recommendations. It doesn't manage pre-operative workups or post-operative follow-up. Patients see a directory of options. They choose.
The Listing Threshold: JCI or Equivalent National Accreditation
JCI accreditation is the primary credentialing filter. In markets with rigorous national systems, such as China's 3A tertiary hospital classification, Sylk Health also lists providers meeting equivalent national standards. No proprietary quality scores. No editorial rankings. No featured placements. Patients see a directory of accredited providers with their published prices.
Sylk Health is paid by the provider on completed treatment. Not by the patient. Not by the insurer. Not by the plan. Not by the employer.
HIPAA Posture: Minimal Data Collection, No BAA Expected
Sylk Health collects less data than almost any vendor in your stack.
What Sylk Health Collects
No data from you. No data identifying your members as plan participants.
Sylk Health doesn't receive member rosters, eligibility files, claims data, demographic information, or any data that identifies an individual as a member of your plan.
When a person uses the Sylk Health marketplace, the only data retained is:
- An auto-assigned ID string (not derived from any external identifier)
- The email address the user provided
- The procedure the user requested a consultation for
That's the complete data record. No names. No dates of birth. No insurance IDs. No diagnosis codes. No medical history.
Why No BAA Is Expected to Be Required
A BAA is required under HIPAA when a vendor creates, receives, maintains, or transmits protected health information on behalf of a covered entity. Sylk Health's system is designed to minimise data collection to an auto-assigned ID, an email address, and a procedure name. This minimal footprint is intended to fall below the PHI threshold. Employers should confirm with their own privacy counsel.
Comparison to Typical Vendor Data Requirements
| Data Element | Typical Vendor | Sylk Health |
|---|---|---|
| Member roster / eligibility file | Required | Not collected |
| Member names, DOB, SSN | Required | Not collected |
| Insurance ID / group number | Required | Not collected |
| Diagnosis / ICD codes | Often required | Not collected |
| Claims data | Often exchanged | Not collected |
| PHI of any kind | Present in system | Minimal by design |
| BAA required | Yes | Not expected to be required |
| HIPAA security review | Required | Minimal exposure |
| Ongoing compliance monitoring | Required | Minimal exposure |
Most international care vendors require months of procurement work: BAA negotiation, security review, eligibility file integration, data-flow mapping, ongoing compliance monitoring. Sylk Health requires none of it. The marketplace sits alongside your existing vendor stack without touching member data, plan data, or claims data.
How to Add an International Provider Directory to a Health Plan
Make the directory available as a member resource. That's the full scope.
No Eligibility Files, Minimal Data Exchange
Sylk Health doesn't need your member roster. No member-identifiable data flows between your plan and Sylk Health. Members are known to Sylk Health only by an auto-assigned ID and the email address they provide when booking a consultation. No names. No demographics. No diagnosis codes. No insurance identifiers. Based on this minimal data posture, a BAA is not expected to be required under HIPAA.
No platform fee. No subscription. No per-member charge.
No TPA renegotiation. Sylk Health sits alongside existing provider arrangements. If a plan wants to formally recognise international care as a covered benefit, that requires a plan-document amendment, typically a straightforward addition to the out-of-network or voluntary-benefit section. Many plans start by just listing Sylk Health in member materials, with no plan-document change at all.
Typical vendor implementation: 4-6 weeks, eligibility file exchange, TPA renegotiation, and $6-$35 PEPM. Sylk Health requires adding a link to your member portal. Done.
What a Lightweight Agreement Covers
Where counsel requires a written agreement, Sylk Health provides one covering basic representations, indemnification, and scope. It doesn't create data-sharing obligations, clinical responsibilities, or integration requirements. There are none to create.
Steps to make the directory available to members:
- 1Review the marketplace directory and pricing data
- 2Decide on plan-document language (simple amendment if you want formal benefit recognition)
- 3Execute a lightweight agreement where counsel requires it
- 4Add the directory to member resources (intranet, benefits portal, or direct link)
- 5Members search, compare, and book consultations on their own
- 6No eligibility files, no PHI exchange, no ongoing administration
The process from first conversation to members having access should take less than 30 days.
What Utilisation Looks Like
44% of large employers already offer medical travel benefits (Mercer, 2022). Domestic COE programmes at Walmart and Lowe's see 0.3% of the workforce use the benefit annually. That sounds low until you consider that the top 1% of claimants drive 28% of plan costs. You don't need mass adoption. You need the 8-12 employees per 1,000 who face a $50K+ procedure to see a $10K international alternative before they commit.
And because Sylk Health costs the plan nothing, the utilisation threshold for positive ROI is zero. Even if nobody uses it, you retain the pricing data as fiduciary documentation.
Healthcare Costs by Country: US vs. International Procedure Pricing
The following table compares US commercial prices with representative international prices for common high-cost procedures. Every figure is attributed to a named source.
| Procedure | US Commercial Price | International Price Examples | US Source | Int'l Source |
|---|---|---|---|---|
| Coronary Artery Bypass (CABG) | $57,240 - $89,094 | India $7,900 | Spain $10,734 | Turkey $13,900 | iFHP 2024, JAHA 2024, Trilliant 2025 | iFHP 2024 |
| Hip Replacement (Total) | $28,167 - $50,564 | India $7,200 | Spain $6,623 | Turkey $13,900 | Trilliant 2025, World Population Review 2025 | iFHP 2024, World Population Review 2025 |
| Spinal Fusion (Single Level) | $80,000 - $150,000 | Thailand $9,500 | India $10,300 | Mexico $15,400 | PLOS ONE 2024 / HCUP NIS | iFHP 2024 |
| Knee Replacement (Total) | $35,000 - $50,564 | India $6,600 | Turkey $10,400 | Thailand $14,000 | Trilliant 2025, KFF/CostHelper | iFHP 2024, World Population Review 2025 |
| Heart Valve Replacement | $71,312 | India $8,000 - $15,000 | Turkey $17,200 | Thailand $33,200 | AHA Circulation 2024 | iFHP 2024, OECD Health at a Glance 2025 |
| Bariatric Surgery (Gastric Bypass) | $20,000 - $35,000 | Turkey $2,150 - $6,500 | India $4,500 - $7,000 | Mexico $5,490 | ASMBS, ACS 2024 | iFHP 2024, World Population Review 2025 |
| Hysterectomy | $12,533 - $15,000 | India $2,700 - $3,200 | Mexico $4,900 - $5,500 | CostHelper 2024 | World Population Review 2025 |
| Prostatectomy (Radical) | $34,720 | India $4,500 - $7,500 | Mexico $5,565 - $8,000 | CostHelper 2024 | World Population Review 2025 |
US commercial prices are drawn from published price transparency data (Trilliant Health 2025, Turquoise Health, JAHA 2024), the iFHP 2024 International Healthcare Cost Comparison Report, and the RAND Corporation Hospital Price Transparency Study (Round 5.1, 2024). International prices are from the iFHP 2024 report, World Population Review 2025, and OECD Health at a Glance 2025.
Actual savings depend on the provider selected, individual case complexity, and existing coverage. Trilliant Health found up to 9-fold variation for the same procedure across US hospitals. Sylk Health doesn't set, verify, or guarantee provider pricing.
JCI Accreditation: International Hospital Quality Standards
The leading international standard for hospital accreditation.
What JCI Accreditation Covers
JCI accreditation is an international hospital quality certification from the Joint Commission International, the same body that accredits the majority of US hospitals. JCI evaluates hospitals against more than 1,400 patient safety and quality standards covering clinical care, infection control, medication management, facility safety, patient rights, and governance. Over 1,100 hospitals in more than 70 countries hold JCI accreditation as of 2026.
In markets with rigorous national systems, such as China's 3A tertiary hospital classification, Sylk Health also lists providers meeting equivalent national standards.
Providers listed on the Sylk Health marketplace are required to hold current JCI or equivalent national accreditation. JCI accreditation isn't a Sylk Health endorsement. It's an independent accreditation body with a 25-year track record. JCI requires on-site evaluation every three years.
Sylk Health doesn't select, rank, or recommend providers. The marketplace displays published prices, wait times, and consultation availability. Patients choose their own provider. Browse accredited providers by specialty
Clinical Evidence from International Registries
A 2025 systematic review of 14 peer-reviewed studies, published in PLoS One (Vuohijoki et al., 2025), found JCI accreditation consistently associated with medication error reductions of 57-61%, improved infection control compliance, and stronger documentation practices. A longitudinal study in BMJ Open (Devkaran et al., 2019) showed quality compliance at JCI-accredited hospitals rising from 89% to over 97% across successive accreditation cycles over eight years.
The Commonwealth Fund's Mirror, Mirror 2024 study ranked the US last among 10 high-income countries in overall health system performance, despite ranking second in clinical care quality. Clinical quality exists outside the US. OECD data across 38 member nations confirms that 30-day post-surgical mortality has declined in nearly every country over the past decade.
International JCI-accredited hospitals perform high volumes of complex procedures. Outcome data is published by the hospitals themselves and by international clinical registries. The Chinese Cardiac Surgery Registry, for example, covers 74+ tertiary hospitals and provides population-level outcome data cited increasingly in international cardiology literature.
But the evidence base has real limitations. A systematic review by Brubakk et al. (2015, BMC Health Services Research) found only one randomised controlled trial meeting rigorous criteria, and concluded that RCT evidence for accreditation's effectiveness remains limited. The observational evidence is positive. The evidence base is still developing. Orthopaedic, bariatric, and oncology outcome data from international centres varies by institution and by country.
Sylk Health's position: provide the information that exists (accreditation status, provider-reported volume and wait times) and let patients and their physicians make informed decisions. We don't claim that international care is equivalent to US care across every procedure, every institution, and every scenario. We do claim that JCI-accredited institutions meet a defined international standard, and that for specific high-volume procedures at specific high-volume centres, the published clinical evidence is substantial. Read about hip replacement outcomes and pricing
Sylk Health is a marketplace that provides access to a directory of JCI or equivalent nationally accredited international healthcare providers. Sylk Health does not provide medical care, coordinate clinical services, or endorse specific providers. All providers listed on the marketplace are independent. Clinical outcomes are the responsibility of the treating provider. Patients should consult their own physicians before making treatment decisions. Provider-listed prices are published by the providers themselves. Sylk Health does not set, verify, or guarantee provider pricing. Actual costs may vary based on individual case complexity, provider selection, and treatment requirements.
Stop-Loss Carriers
The procedures driving the largest US-to-international price gaps are the same ones triggering stop-loss claims. Cardiac, spinal, orthopaedic, bariatric. Since Sylk Health costs the carrier nothing, the utilisation threshold for positive impact is zero.
Healthshare Ministries
Members already pay cash. No MLR constraints, no network restrictions. International pricing reduces the sharing burden per eligible need. Samaritan Ministries already encourages medical travel. Sylk Health replaces the manual search.
Commercial Structure: Zero Cost to the Plan
There's no platform fee. No subscription. No per-member charge. No implementation fee. No data-exchange cost, because there's no data exchange.
That's the short answer.
44% of large employers already offer at least one medical travel benefit (Mercer, 2022, 701 organisations). The concept of making non-local providers available to members is established. What those programs typically require (care coordination, data integration, per-member fees) is where Sylk Health differs. Sylk Health is a directory with published pricing. No coordination. No integration. No fee.
Sylk Health is paid by the provider. When a member books a consultation through the marketplace and completes treatment with that provider, the provider pays a commission. The commission comes out of the provider's revenue. It isn't added on top of what the member pays.
Brokers and affiliates who refer plan clients to Sylk Health receive a portion of that commission, paid from Sylk Health's share. It's never an additional cost to the plan, the member, or the employer. Broker compensation is disclosed to the employer as part of the broker agreement.
The commercial flow, in full: provider pays Sylk Health on completed treatment. Sylk pays the referring broker or affiliate from its own revenue. No other party pays anything.
The practical takeaway for procurement: there's no budget line item. There's no contract with financial terms flowing from plan to vendor. The procurement decision is whether to list a free resource in member materials.
ERISA and International Healthcare: The Regulatory Framework
General information about recent legal and regulatory developments. This isn't legal advice. Plan administrators should consult their own ERISA counsel on plan-specific implications.
Post-Stern: Plan Design as Settlor Function
In March 2026, the Southern District of New York ruled in Stern v. JPMorgan Chase & Co. that plan design decisions, including which provider directories to make available to members, are settlor functions, not fiduciary functions under ERISA. A plan administrator can't be sued as a fiduciary for choosing to include or exclude specific provider categories.
Separately, the prohibited transaction claim under ERISA Section 406 survived. Following Cunningham v. Cornell University (SCOTUS, 2025), the burden of proving compensation reasonableness now falls on the service provider, not the plaintiff.
Tiara Yachts Inc. (6th Circuit, 2025) held that TPAs exercising discretionary authority over plan assets are functional fiduciaries, and that causing a plan to overpay for medical claims can constitute a fiduciary breach.
In April 2026, DOL Field Assistance Bulletin 2026-01 reinforced that "ERISA is a law of process, not results." Fiduciaries who document a thorough cost evaluation process are protected, even when they make unconventional plan design choices.
The fiduciary litigation wave is picking up speed. In 2025 alone, 155 ERISA fiduciary suits were filed (98 targeting defined contribution plans, 39 targeting health plans), with a new wave of voluntary benefits class actions extending fiduciary scrutiny to every category of plan spending.
The combined signal: plan design choices are protected. But intermediary compensation must be demonstrably reasonable.
Marketplace Precedent: Healthcare Directory Platforms
HHS-OIG issued two Advisory Opinions (AO 19-04 and AO 23-04) evaluating Zocdoc's healthcare directory and booking platform, finding that while the model implicates the Anti-Kickback Statute, it doesn't warrant enforcement action when fees are set in advance at fair market value, aren't tied to referral volume, and the platform doesn't influence patient choices. In Sisselman v. Zocdoc (2d Cir. 2025), the Second Circuit affirmed dismissal, finding Zocdoc's reliance on these OIG opinions demonstrated good faith.
International Price Benchmarks and Compensation Reasonableness
In 2026, Congress, the DOL, and the FTC each took action to increase healthcare cost transparency, including new PBM disclosure requirements under ERISA Section 408(b)(2), DOL proposed regulations requiring advance fee disclosures from PBMs, and the FTC's structural pricing transparency requirements in the Express Scripts settlement.
The regulatory direction is clear. Plan fiduciaries are expected to evaluate whether the prices their plans pay, and the fees their intermediaries charge, are reasonable.
Sylk Health's international price benchmarks provide one external reference point for that evaluation. JCI or equivalent nationally accredited international providers list prices for the same high-cost procedures that drive US plan costs. Sylk Health doesn't advise on what constitutes reasonable compensation. Sylk Health provides the pricing data. Plan fiduciaries and their advisors decide how to use it.
Legal information, not legal advice. The developments described on this page are provided for informational purposes only. This content does not constitute legal advice, fiduciary guidance, or a recommendation regarding any specific plan's arrangements. ERISA compliance depends on the specific facts of each plan. Plan fiduciaries should consult qualified ERISA counsel before making decisions about plan design, intermediary compensation, or benefit offerings. Sylk Health is a marketplace that provides access to a directory of JCI or equivalent nationally accredited international healthcare providers.
Frequently Asked Questions
Common questions from plan administrators, stop-loss carriers, and benefits consultants.
Sylk Health has no role in the member's care. Sylk Health operates a marketplace where JCI or equivalent nationally accredited international providers list their procedures, prices, and consultation availability. Members browse the directory, compare options, and book consultations directly with providers. From that point, the relationship is between member and provider. Sylk Health doesn't coordinate care, arrange logistics, manage clinical decisions, or sit between the patient and the hospital in any capacity.
All medical procedures carry risk, whether performed domestically or internationally. The treating provider is responsible for complications arising from treatment, consistent with their own clinical protocols and the terms of the patient-provider agreement. Sylk Health doesn't provide post-operative care, maintain a US clinical presence, or manage clinical follow-up.
Members should discuss complication management directly with the treating provider before proceeding, including what happens if they return to the US before completing follow-up. Members should also consult with their US-based physicians about continuity of care.
Many patients who travel for international procedures independently purchase complication coverage (sometimes called medical tourism insurance), a standalone product covering follow-up care costs. These policies are available from several international health insurers and are purchased directly by the patient.
Sylk Health's data record for each user consists of an auto-assigned ID, an email address, and the name of the procedure for which a consultation was requested. This minimal data footprint is designed to fall below the PHI threshold under HIPAA. No names, demographics, diagnosis codes, insurance identifiers, or clinical records are collected. Based on this data posture, a BAA is not expected to be required. Employers should confirm with their own privacy counsel.
It doesn't. Sylk Health sits alongside your existing arrangements as an additional resource members can access voluntarily. No TPA renegotiation, no modification to existing provider arrangements, no claims adjudication change. If a plan wants to formally recognise international care as a covered or reimbursable benefit, that requires a plan-document amendment. Many plans start by listing the marketplace in member materials without any plan-document change.
ERISA doesn't prohibit plan sponsors from making international providers available to members. Plan design choices, including which provider directories are accessible, are settlor functions, not fiduciary functions, as reinforced by Stern v. JPMorgan (2026). The relevant question is whether the plan's overall cost structure reflects reasonable compensation, a standard that international price benchmarks directly inform. Plan administrators should consult with their own ERISA counsel on plan-document language and benefit design.
Adding a link, a paragraph, or a section to the materials your members already receive: benefit guides, member portals, open-enrolment communications. No technical integration, no eligibility file, no API connection, no IT project. Where counsel requires a written agreement, Sylk Health provides one covering standard representations and indemnification. The process from first conversation to members having access should take less than 30 days.
JCI accreditation evaluates hospital-level quality systems against more than 1,400 measurable standards. For surgeon-level and procedure-level outcome data, plan administrators and members can request outcome information directly from the provider during the consultation process. Outcome data is published by international hospitals and by international clinical registries. Sylk Health provides the consultation booking; clinical evaluation is between the patient and the provider.
Nothing. No platform fee, subscription, per-member charge, implementation fee, or ongoing cost. Sylk Health is paid by providers on completed treatment. The commission comes from the provider's revenue and isn't added on top of what the member pays.
See How This Works for Your Plan
See the marketplace your members would see, the pricing data for procedures driving your plan costs, and the implementation path.
No commitment. No data exchanged. No cost.
Sylk Health operates an online marketplace listing JCI or equivalent nationally accredited international healthcare providers. Sylk Health is not a healthcare provider, insurance company, health plan, or clinical service. Sylk Health does not provide medical advice, coordinate care, arrange travel, or manage clinical outcomes. All providers listed on the marketplace are independent entities. Patients contract directly with providers. Provider-listed prices are published by the providers themselves and may change without notice. Sylk Health does not set, verify, or guarantee provider pricing. Actual costs depend on individual case complexity, provider selection, and treatment requirements. Content on this page is for informational purposes only and does not constitute medical, legal, actuarial, or fiduciary advice. Plan administrators, carriers, and healthshare ministries should consult their own qualified advisors before making decisions based on information presented here. Sylk Health has no affiliation with any third-party organisation referenced on this page unless explicitly stated.